Meridian Bioscience Announces Preliminary Results for Fiscal 2022 Third Quarter

Go back to Meridian Bioscience Announces Preliminary Results for Fiscal 2022 Third Quarter
Meridian Bioscience, Inc. (NASDAQ: VIVO) Delayed: 3.81 -0.26 (6.39%)
Previous Close $4.07    52 Week High $21.49 
Open $4.01    52 Week Low $15.75 
Day High $4.01    P/E 4.33 
Day Low $3.77    EPS $0.88 
Volume 256,033